Analiza pojavnosti fenetilaminov v skupini novih psihoaktivnih snovi med letoma 2001 in 2022 v Evropi

Pelc, Anamarija (avtor), Sollner Dolenc, Marija (mentor)

Fenetilamini so skupina novih psihoaktivnih snovi (NPS), ki po farmakološkem delovanju spadajo med snovi s stimulatornim ali halucinogenim delovanjem. Vključujejo amfetamin in njegove derivate, ter v večini delujejo po principu spodbujanja razpoložljivosti monoaminskih nevrotransmiterjev v osrednjem živčevju ter na periferiji. Obstaja tudi nekaj derivatov amfetamina, ki se uporabljajo kot zdravilne učinkovine, predvsem za zdravljenje motnje pozornosti s hiperaktivnostjo (ADHD). Zloraba tovrstnih snovi pa lahko vodi v odvisnost in predstavlja tveganje za javno zdravje. Pri našem delu smo se osredotočili na spremljanje pojavnosti vseh zabeleženih primerov in na novo identificiranih primerov fenetilaminov v Evropi, med letoma 2001 in 2022. Pri tem smo kot osnovni vir za pridobivanje podatkov uporabili Evropsko bazo o novih drogah EDND II, dodatno pa so nam bili v pomoč tudi razni strokovni članki, poročila ter ostala na spletu dostopna znanstvena literatura. Ugotovili smo, da je bilo med letoma 2001 in 2022 v Evropi na novo identificiranih 104 različnih fenetilaminov. Največ se jih je pojavilo v obdobju med leti 2012 in 2015, ko so skupno zabeležili 45 različnih predstavnikov. Država, v kateri so zaznali največ na novo odkritih fenetilaminov in kjer so prijavili največ primerov teh snovi, je Švedska. Slovenijo v prvi kategoriji uvrščamo na 6. mesto, v drugi pa na 5. mesto po pojavnosti fenetilaminov v Evropi. Snovi, ki predstavljajo večje tveganje za javno zdravje, so v Sloveniji uvrščene na Seznam prepovedanih drog, na evropskem nivoju pa se za potencialno nevarnejše snovi izda oceno tveganja. Do sedaj je bila izdana za 9 fenetilaminov. Po načinu pojavljanja fenetilaminov prevladujejo zaseženi vzorci, sledijo jim zbrani, ki so v analizo prineseni s strani uporabnikov, najmanj pa je bioloških vzorcev. Glede na obliko izdelkov snovi pa se običajno nahajajo kot praški, tablete ali impregniran papir. Iz poročil o odkritju fenetilaminov razberemo, da je njihova pojavnost v Evropi med letoma 2017 in 2022 v povprečju upadla za okoli 40 % v primerjavi z obdobjem vrhunca njihove pojavnosti, med letoma 2011 in 2016. Ta dosežek lahko pripišemo uspešnemu delu organizacij, ki delujejo v boju proti prepovedanim drogam, zlasti Sistemu za zgodnje opozarjanje (EWS), katerega naloga je pravočasno obveščanje držav članic o pojavu NPS.

• Jezik: Slovenski jezik
• Ključne besede: nove psihoaktivne snovi, fenetilamini, EDND II, EMCDDA, amfetamin in njegovi derivati
• Vrsta gradiva: Magistrsko delo/naloga
• Organizacija: FFA - Fakulteta za farmacijo
• Leto izida: 2023
• PID: 20.500.12556/RUL-146380
• Datum objave v RUL: 26.05.2023

PELC, Anamarija, 2023, Analiza pojavnosti fenetilaminov v skupini novih psihoaktivnih snovi med letoma 2001 in 2022 v Evropi [na spletu]. Magistrsko delo. [Dostopano 4 maj 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=146380

Sekundarni jezik

• Jezik: Angleški jezik
• Naslov: Analysis of phenethylamines incidence in a group of new psychoactive substances between 2001 and 2022 in Europe

Izvleček

Phenethylamines are a group of new psychoactive substances that, according to their pharmacological action, belong to substances with a stimulatory or hallucinogenic effect. They include amphetamine and its derivatives and mostly work on the principle of stimulating the availability of monoamine neurotransmitters in the central nervous system and in the periphery. There are also some amphetamine derivatives that are used as medicinal substances, mainly for the treatment of attention deficit hyperactivity disorder (ADHD). The abuse of such substances can lead to addiction and pose a risk to public health. In our work, we focused on monitoring the incidence of all recorded cases and newly identified cases of phenethylamines in Europe between 2001 and 2022. We used as the basic source for data acquisition, the European database of new drugs EDND II, and additionally, various professional articles, reports and other scientific literature avaliable online. We found out that 104 different phenethylamines were newly identified in Europe between 2001 and 2022. Most of them appeared in the period between 2012 and 2015, when a total of 45 different representatives were recorded. The country that detected the largest number of newly discovered phenethylamines and where the most cases of these substances were reported is Sweden. Slovenia is ranked on the 6th place in the first category and on the 5th place in the second category in terms of the occurrence of phenethylamines in Europe. Substances that pose a greater risk to public health are in Slovenia included on the List of Prohibited Drugs. At the European level a risk assessment is issued for potentially more dangerous substances. So far, it has been issued for 9 phenethylamines. According to the mode of appearance of phenethylamines, seized samples dominate, followed by collected ones brought for analysis by users, and biological samples are the least abundant. Depending on the product form substances are usually found as powders, tablets or impregnated paper. From reports about discovery of phenethylamines, we can see that their occurrence in Europe has decreased by around 40 % on average between 2017 and 2022, compared to the peak period of their occurrence, between 2011 and 2016. This achievement can be attributed to the successful work of organizations operating in the fight against illegal drugs, especially the Early Warning System (EWS), whose task is to inform member states in a timely manner about the occurrence of NPS.

• Ključne besede: new psychoactive substances, phenethylamines, EDND II, EMCDDA, amphetamine and its derivatives